Rock Springs Capital Management LP Abb Vie Inc. Transaction History

Rock Springs Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $37.9 Million - $47.4 Million	-525,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $23.6 Million - $28.4 Million	375,000 Added 250.0%	525,000 $39.8 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $9.86 Million - $12.6 Million	150,000 New	150,000 $10.9 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $25.3 Million - $31.2 Million	-325,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $24.5 Million - $27.2 Million	-275,000 Reduced 45.83%	325,000 $30.7 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $55.2 Million - $73.9 Million	600,000 New	600,000 $56.8 Million

3,855

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.